880228 | DSPE-PEG(2000) Azide
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[azido(polyethylene glycol)-2000] (ammonium salt)
DSPE-PEG(2000) Azide
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[azido(polyethylene glycol)-2000] (ammonium salt)
Representative Structure
The molecular weight and exact mass are averages based on the polydispersity of PEG.
C132H264N5O54P (average MW due to polydispersity of PEG)
C 56.29%, H 9.45%, N 2.49%, O 30.67%, P 1.10%
- ChemDraw File
- 3D Structure
- Structure
- Safety Data Sheet
- Safety Data Sheet
Xiao Y, Liu Q, Clulow AJ, Li T, Manohar M, Gilbert EP, de Campo L, Hawley A, Boyd BJ. PEGylation and surface functionalization of liposomes containing drug nanocrystals for cell-targeted delivery. Colloids Surf B Biointerfaces. 2019 Jul 15;182:110362. doi: 10.1016/j.colsurfb.2019.110362. [Epub ahead of print]
PubMed ID: 31351271Girish A, Hickman DA, Banerjee A, Luc N, Ma Y, Miyazawa K, Sekhon UDS, Sun M, Huang S, Sen Gupta A. Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model. J Thromb Haemost. 2019 Jun 20. doi: 10.1111/jth.14552. [Epub ahead of print]
PubMed ID: 31220416Paek J, Park SE, Lu Q, Park KT, Cho M, Oh JM, Kwon KW, Yi YS, Song JW, Edelstein HI, Ishibashi J, Yang W, Myerson JW, Kiseleva RY, Aprelev P, Hood ED, Stambolian D, Seale P, Muzykantov VR, Huh D. Microphysiological Engineering of Self-Assembled and Perfusable Microvascular Beds for the Production of Vascularized Three-Dimensional Human Microtissues. ACS Nano. 2019 Jun 18. doi: 10.1021/acsnano.9b00686. [Epub ahead of print]
PubMed ID: 31194909Hood ED, Greineder CF, Shuvaeva T, Walsh L, Villa CH, Muzykantov VR. Vascular targeting of radiolabeled liposomes with bio-orthogonally conjugated ligands: single chain fragments provide higher specificity than antibodies. Bioconjug Chem. 2018 Sep 21. doi: 10.1021/acs.bioconjchem.8b00564. [Epub ahead of print]
PubMed ID: 30240185Jewett, J.C., E.M. Sletten, and C.R. Bertozzi. (2010). Rapid Cu-free click chemistry with readily synthesized biarylazacyclooctynones. J Am Chem Soc 132:3688-90.
PubMed ID: 20187640- Certificate of Analysis(Lot No. 880228C-10MG-A-012and 6307CIA012)
- Certificate of Analysis(Lot No. 880228P-100MG-A-012and 6307PLA012)
- Certificate of Analysis(Lot No. 880228P-10MG-A-012and 6307PIA012)
- Certificate of Analysis(Lot No. 880228P-25MG-A-012and 6307PJA012)
- Certificate of Analysis(Lot No. 880228P-500MG-A-012and 6307PPA012)
- Certificate of Analysis(Lot No. 880228P-50MG-A-012and 6307PKA012)
- Certificate of Analysis(Lot No. 880228P-50MG-A-013and 6307PKA01)
- Certificate of Analysis(Lot No. 880228P-100MG-A-013and 6307PLA013)
- Certificate of Analysis(Lot No. 880228P-25MG-A-013-6307PJA013and 6307PJA013)
- Certificate of Analysis(Lot No. 880228P-50MG-B-013and 6307PKB013)
- Certificate of Analysis(Lot No. 880228P-10MG-B-013and 6307PIB013)
- Certificate of Analysis(Lot No. 880228P-10MG-C-013and 6307PIC013)
- Certificate of Analysis(Lot No. 880228C-10MG-A-013and 6307CIA013)
- Certificate of Analysis(Lot No. 880228P-100MG-B-013and 6307PLB013)
- Certificate of Analysis(Lot No. 880228C-10MG-B-013and 6307CIB013)
- Certificate of Analysis(Lot No. 880228P-50MG-C-013and 6307PKC013)
- Certificate of Analysis(Lot No. 880228P-25MG-B-012and 6307PJB012)
- Certificate of Analysis(Lot No. 880228P-100MG-B-012and 6307PLB012)
- Certificate of Analysis(Lot No. 880228P-100MG-D-012and 6307PLD012)
- Certificate of Analysis(Lot No. 880228P-25MG-B-013and 6307PJB013)
- Certificate of Analysis(Lot No. 880228P-100MG-C-013and 6307PLC013)
- Certificate of Analysis(Lot No. 880228P-50MG-D-013and 6307PKD013)
- Certificate of Analysis(Lot No. 880228P-10MG-A-013and 6307PIA013)
- Certificate of Analysis(Lot No. 880228P-25MG-C-013and 6307PJC013)
- Certificate of Analysis(Lot No. 880228P-100MG-D-013and 6307PLD013)
- Certificate of Analysis(Lot No. 880228P-50MG-E-013and 6307PKE013)
- Certificate of Analysis(Lot No. 880228P-10MG-D-013and 6307PID013)
- Certificate of Analysis(Lot No. 880228P-50MG-F-013and 6307PKF013)
- Certificate of Analysis(Lot No. 880228P-50MG-G-013and 6307PKG013)
- Certificate of Analysis(Lot No. 880228P-25MG-D-013and 6307PJD013)
- Certificate of Analysis(Lot No. 880228P-100MG-E-013and 6307PLE013)
- Certificate of Analysis(Lot No. 880228P-100MG-F-013and 6307PLF013)
- Certificate of Analysis(Lot No. 880228P-10MG-F-013and 6307PIF013)
- Certificate of Analysis(Lot No. 880228P-25MG-A-014and 6307PJA014)
- Certificate of Analysis(Lot No. 880228P-50MG-A-014and 6307PKA014)
- Certificate of Analysis(Lot No. 880228C-10MG-A-014and 6307CIA014)
- Certificate of Analysis(Lot No. 880228P-100MG-A-014and 6307PLA014)
- Certificate of Analysis(Lot No. 880228P-100MG-B-014and 6307PLB014)
- Certificate of Analysis(Lot No. 880228P-50MG-B-014and 6307PKB014)
Avanti Polar Lipids公司是美国著名的磷脂类产品的生产商，该公司主要为各种制药厂和研究机构提供从毫克级到公斤级乃至吨级的磷脂类和甾体类中间体和试剂。为世界范围内的研究机构和制药公司提供 1000 种以上脂类产品，由于其产品的高纯度而享誉全球。40年来，Avanti Polar Lipids公司为世界各地的研究人员和制药公司提供脂类产品。公司的产品不仅范围日益扩大，其纯度之高也是无人能及。
Avanti Polar Lipids, Inc., has a long history of 50 years creating the highest purity lipids available. Our passion for high quality and unique products is only exceeded by our excellent reputation in the marketplace. Although we are known for our lipids, we are More than Lipids. We offer solutions for the entire product cycle…Research to Commercialization.
Avanti Polar Lipids公司的主要产品和服务包括：
（1）Research Products
Highest Purity Lipid Reagents
（2）cGMP Manufacturing
API & Contract Manufacturing
（3）Adjuvants
Immunotherapy & Vaccine Development
（4）Analytical Services
Lipid Analysis
（5）Lipidomics
Mass Spec Standards, Antibodies & Lipid Toolbox
（6）Formulations
Liposomes & Nanoparticles
（7）Equipment
Liposome Production Tools
（8）Custom Services
Synthesis & Beyond
本网站将在规定时间内给予删除等相关处理。
